NYSE (USA) TSX (CANADA)

Directory of Stock Market Company

This site is a directory of Stock Market Company in USA and Canada. Each company page contains a description, stock quote, news and much more. You have also access to the best stock market game on the web.

Search into NYSE and TSX
by quote, company name or key word

facebooktwitterlinkedin
Mail

AFFY - Affymax Inc

Affymax, Inc., incorporated on July 20, 2001, is a biopharmaceutical company developing drugs to improve the treatment of serious and often life-threatening conditions. Its product candidate, Hematide (peginesatide), is designed to treat anemia associated with chronic renal failure. Hematide is a synthetic peptide-based erythropoiesis stimulating agent (ESA) designed to stimulate production of red blood cells. The Company completed ","NYSE, Nasdaq, S&P, trading, US market, Asian market, Dow Jones, FTSE, DJIA, DAX, stocks, bonds, shares","Connect to the most current information on stocks and bonds on Reuters.com. What you need to know now about NYSE, Dow Jones, S&P, and Nasdaq at Reuters.com"

# AFFYhart

Affymax Inc News


A Slam Bang Day Today
AdviceTrade - 6 hours ago
by Harry Boxer, www.TheTechTrader.com The stock market indices had a slam-bang day up. But with the oscillators, as oversold as they were going into today, along with the cycle lows and everything else in tune, we expected a strong snapback move as ...
Slam Bang Day Today - FXstreet.com

Analysts' Ratings Reiterations for May, 21st (AFFY, AMAT, BLK, COST, CPB, DTV ...
Junction Report - 10 hours ago
Affymax, Inc. (NASDAQ: AFFY) had its “buy” rating re-affirmed by analysts at McNicoll Lewis & Vlak. Applied Materials, Inc. (NASDAQ: AMAT) had its “outperform” rating re-affirmed by analysts at Oppenheimer.

Streetinsider.com's Hot Lunchtime Reads 05/21: (AAPL) (FB) (LVS) (AFFY) (GDP)
StreetInsider.com (subscription) - 12 hours ago
Analyst Sees Affymax's (AFFY) Omontys as Comparable to Amgen's (AMGN) Epogen; Raises AFFY Target to $21 -> Read this! UBS Maintains a 'Buy' on Las Vegas Sands (LVS); Revising Singapore Market Estimates -> Read this!

Analyst Sees Affymax's (AFFY) Omontys as Comparable to Amgen's (AMGN) Epogen ...
StreetInsider.com (subscription) - 12 hours ago
Shares of Affymax, Inc. (NASDAQ: AFFY) are up a sharp 7.3 percent Monday, potentially on the heels of a raised price target from McNicoll Lewis & Vlak's Ed Arce earlier.

Research Analysts' Price Target Changes for May, 21st (AFFY, AMD, BBG, CTRP ...
Junction Report - 13 hours ago
Affymax, Inc. (NASDAQ: AFFY) had its price target raised by analysts at MLV & Co from $12.00 to $21.00. They now have a “buy” rating on the stock.

5% Fund Ownership Filings In Healthcare: 2 Surging And 2 Plunging Stocks ...
Seeking Alpha - May 15, 2012
Many leading funds, including SAC Capital, Fidelity Investments, and Wellington Management, filed forms 13-D and 13-G (and form 4) with the SEC last week (May 7th to 11th, 2012), indicating that they had amended their ownership in US traded public ...

ADY, INSP, GDI, VMW Among Charts to Watch
AdviceTrade - May 11, 2012
by Harry Boxer, www.TheTechTrader.com It was a sloppy day on Wall Street on Thursday, but the session ended on an up note as it snapped back in the last 5 minutes.

WBB Securities Cuts Affymax to Buy (AFFY)
Daily Political - May 9, 2012
Affymax (NASDAQ: AFFY) was downgraded by research analysts at WBB Securities from a “strong-buy” rating to a “buy” rating in a report released on Tuesday.

Analysts' Downgrades for May, 8th (ACM, AFFY, AMX, AUMN, BAH, BP, CPE, DNDN ...
Junction Report - May 8, 2012
AECOM Technology Co. (NYSE: ACM) was downgraded by analysts at Bank of America from a “buy” rating to an “underperform” rating.

INSM, VRTX, GLNG, STZ Among Charts to Watch
AdviceTrade - May 8, 2012
by Harry Boxer, www.TheTechTrader.com The stock market had an interesting session on Monday. They were down early, rallied back the rest of the session, and then rolled over the last hour, or so.

NYSE Media Coverage Selection of the best articles found in your favorit medias

Next Company >>